- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06454084
Investigation of Endothelium-dependent Vasodilation in Human Gingiva
Investigation of Endothelium-dependent Vasodilation in Human Gingiva Depending on Serum Estrogen Level
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gender differences were observed in studies according to gingival microcirculation between physiological circumstances and during wound healing as well.
For blood flow measurement, Laser Speckle Contrast Imaging is a reliable tool. It has good reproducibility, does not touch the measured surface, is easy to use, and can simultaneously measure on a bigger surface.
Two wells are fabricated on the surface of the right lateral incisor (test site) and the labial surface of the left central incisor (control site). These wells are opened towards the high-permeability gingival sulcus, so the dropped solutions acetylcholine vs. physiological saline can easily penetrate the gingival tissues. After applying the solutions, the blood flow is monitored for 19 minutes.
In the study's second phase, blood sampling is taken before the gingival blood flow measurement.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Budapest, Hungary, 1088
- Department for Restorative Dentistry and Endodontics, Semmelweis University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- healthy systemic and periodontal conditions
Exclusion Criteria:
- systemic disease and medication
- periodontal disease
- smoking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acetylcholine 0,1 mg/mL and 1 mg/mL and 10 mg/mL
Vasodilator solution is dropped on the labial surface of the lateral incisor, which penetrates into the gingival sulcus. In the dose-response study, 0,1 mg/mL, 1 mg/mL, and 10 mg/mL acetylcholine solution is dropped into the gingival sulcus, and every solution remains there for 2:30 minutes between them is always a 30-second long pause. In the second phase of the study, where the sex differences are monitored, 10 mg/mL acetylcholine solution is dropped into the gingival sulcus for 15 minutes |
Vasodilator solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. Blood flow change after applying the test solution
Time Frame: 19 minutes
|
The change in blood flow will be measured after applying the test solution
|
19 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/2025
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vasodilation
-
Colorado State UniversityWithdrawnVasodilation | VasoconstrictionUnited States
-
Universidade Federal do Rio Grande (FURG)Completed
-
University of AlbertaCompletedVasodilation | VasoconstrictionCanada
-
University of AlbertaCompletedVasodilation | VasoconstrictionCanada
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedVasodilation | MethotrexateNetherlands
-
Columbia UniversityTerminated
-
Semmelweis UniversityCompletedVasodilation | Nitric Oxide | Oral Soft Tissue ConditionsHungary
-
University of MilanCompletedVasodilation | Vasoconstriction | Stretch | Sympathetic; ImbalanceItaly
-
University of AlbertaRecruitingVasodilation | VasoconstrictionCanada
-
Korea Ginseng CorporationNutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedCardiovascular Diseases | Platelet Aggregation | Vasodilation | Blood Pressure DisordersUnited States
Clinical Trials on Acetylcholine Chloride
-
South Valley UniversityRecruitingType 2 Diabetes Mellitus | Peripheral NeuropathyEgypt
-
McMaster UniversityHamilton Health Sciences CorporationCompleted
-
University of JenaCompletedCystic Fibrosis | RhinosinusitisGermany
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation TrustCompletedNeuromuscular DiseasesUnited Kingdom
-
Aga Khan UniversityUnknownAcute HypokalemiaPakistan
-
National Cancer Institute (NCI)CompletedUlcerative ColitisUnited States, China
-
Bristol-Myers SquibbRecruitingSchizophreniaUnited States
-
Federal University of São PauloCompleted
-
New York State Psychiatric InstituteBristol-Myers SquibbNot yet recruitingSchizoaffecitve Disorder | SCHIZOPHRENIA 1 (Disorder)United States
-
Karuna TherapeuticsKaruna Therapeutics, Inc., a Bristol Myers Squibb companyRecruitingHealthy VolunteersUnited States